Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mayo

Showing results (331-340 of 375) with videos related to

Pageof 38
Sort By:
Phytotherapy Research : PTR|January 24, 2017
Anthelmintic, Antibacterial and Cytotoxicity Activity of Imidazole Alkaloids from Pilocarpus microphyllus LeavesJefferson A Rocha, Ivanilza M Andrade, Leiz M C Véras, et al.
Nature Reviews. Gastroenterology & Hepatology|February 19, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter viewDavid E J Jones, Robert Mitchell-Thain, Emma L Culver, et al.
BMC Microbiology|April 3, 2007
Tandem repeat regions within the Burkholderia pseudomallei genome and their application for high resolution genotypingJana M U'Ren, James M Schupp, Talima Pearson, et al.
Cancer Research|December 17, 2013
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingKathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
BMC Pulmonary Medicine|August 24, 2021
Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and diseaseM Tomchaney, M Contoli, J Mayo, et al.
The American Journal of Gastroenterology|June 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study ResultsCynthia Levy, Palak J Trivedi, Kris V Kowdley, et al.
Journal of Hepatology|April 14, 2019
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitisMaren H Harms, Henk R van Buuren, Christophe Corpechot, et al.
Gut|January 9, 2015
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international studyPalak J Trivedi, Willem J Lammers, Henk R van Buuren, et al.
BMC Public Health|November 9, 2021
Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE studyMorgan Garcia, Ellen Luecke, Ashley J Mayo, et al.
Hepatology (Baltimore, Md.)|October 11, 2008
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assayMarlyn J Mayo, Julie Parkes, Beverley Adams-Huet, et al.
Pageof 38

Showing results (331-340 of 375) with videos related to

Sort By:
Pageof 38
Phytotherapy Research : PTR|January 24, 2017
Anthelmintic, Antibacterial and Cytotoxicity Activity of Imidazole Alkaloids from Pilocarpus microphyllus LeavesJefferson A Rocha, Ivanilza M Andrade, Leiz M C Véras, et al.
Nature Reviews. Gastroenterology & Hepatology|February 19, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter viewDavid E J Jones, Robert Mitchell-Thain, Emma L Culver, et al.
BMC Microbiology|April 3, 2007
Tandem repeat regions within the Burkholderia pseudomallei genome and their application for high resolution genotypingJana M U'Ren, James M Schupp, Talima Pearson, et al.
Cancer Research|December 17, 2013
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profilingKathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
BMC Pulmonary Medicine|August 24, 2021
Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and diseaseM Tomchaney, M Contoli, J Mayo, et al.
The American Journal of Gastroenterology|June 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study ResultsCynthia Levy, Palak J Trivedi, Kris V Kowdley, et al.
Journal of Hepatology|April 14, 2019
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitisMaren H Harms, Henk R van Buuren, Christophe Corpechot, et al.
Gut|January 9, 2015
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international studyPalak J Trivedi, Willem J Lammers, Henk R van Buuren, et al.
BMC Public Health|November 9, 2021
Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE studyMorgan Garcia, Ellen Luecke, Ashley J Mayo, et al.
Hepatology (Baltimore, Md.)|October 11, 2008
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assayMarlyn J Mayo, Julie Parkes, Beverley Adams-Huet, et al.
Pageof 38